Increased FAM26F expression was also associated with clearance of hepatitis C virus (Grimes et al., 2013) and clinical benefit through immune-based MAGE-A3 therapy in melanoma patients (Ulloa-Montoya et al., 2013). The gene discussed is MAGEA3; the disease is melanoma.